In the last trading session, 1.19 million Aptose Biosciences Inc (NASDAQ:APTO) shares changed hands as the company’s beta touched 0.93. With the company’s per share price at $0.19 changed hands at $0.01 or 1.47% during last session, the market valuation stood at $11.11M. APTO’s last price was a discount, traded about -1431.58% off its 52-week high of $2.91. The share price had its 52-week low at $0.13, which suggests the last value was 31.58% up since then. When we look at Aptose Biosciences Inc’s average trading volume, we note the 10-day average is 1.94 million shares, with the 3-month average coming to 711.78K.
Analysts gave the Aptose Biosciences Inc (APTO) stock a consensus recommendation rating of Buy, calculated at a mean rating of 1.00. If we narrow down to specifics, the data shows that 0 out of 3 analysts rate the stock as a Sell, with a further 0 assigning it an Overweight rating. Of the remaining, 0 recommended APTO as a Hold, 3 felt it is a Buy and 0 rated the stock as Underweight. Aptose Biosciences Inc’s EPS for the current quarter is expected to be -0.35.
Aptose Biosciences Inc (NASDAQ:APTO) trade information
Instantly APTO was in green as seen at the end of in last trading. With action 1.36%, the performance over the past five days has been green. The company’s shares are showing year-to-date downside of -92.65%, with the 5-day performance at 1.36% in the green. However, in the 30-day time frame, Aptose Biosciences Inc (NASDAQ:APTO) is -50.92% down. Looking at the short shares, we see there were 0.12 million shares sold at short interest cover period of 1.61 days.
Aptose Biosciences Inc (APTO) estimates and forecasts
Data shows that the Aptose Biosciences Inc share is performing relatively much better than most of its peers within the same industry. As can be gleaned from the statistics, the company’s share value shot -80.35% over the past 6 months, a 76.39% in annual growth rate that is considerably higher than the industry average of 17.60%.
According to analysts, the company will likely register a growth in its current quarter sales, forecast at 0.00%.
Looking at the company’s year-on-year earnings, data shows that the past 5-year has an earnings growth rate of 10.18%. The 2024 estimates are for Aptose Biosciences Inc earnings to increase by 76.39%.
APTO Dividends
Aptose Biosciences Inc is expected to release its next quarterly earnings report in January.
Aptose Biosciences Inc (NASDAQ:APTO)’s Major holders
If we look at who the major shareholders are, we find that insiders hold 16.39% of Aptose Biosciences Inc shares while 16.68% of the shares are in the hands of institutional holders. The share float percentage for the stock currently stands at 19.96%. There are 16.68% institutions holding the Aptose Biosciences Inc stock share, with DOHENY ASSET MANAGEMENT /CA the top institutional holder. As of 2024-06-30, the company held 0.3849% of the shares, roughly 50550.0 APTO shares worth $0.32 million.
CALDWELL SUTTER CAPITAL, INC. holds the second largest percentage of outstanding shares, with 0.0007% or 92.0 shares worth $70.0 as of 2024-06-30.
